Great West Life Assurance CO Denali Therapeutics Inc. Transaction History
Great West Life Assurance CO
- $53.1 Billion
- Q2 2024
A detailed history of Great West Life Assurance CO transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 13,434 shares of DNLI stock, worth $412,155. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,434
Previous 9,724
38.15%
Holding current value
$412,155
Previous $200,000
56.0%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding DNLI
# of Institutions
214Shares Held
121MCall Options Held
127KPut Options Held
38.3K-
Baillie Gifford & CO13.8MShares$422 Million0.25% of portfolio
-
Black Rock Inc. New York, NY13.2MShares$404 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$347 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA9.82MShares$301 Million0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.13MShares$219 Million0.04% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $4.12B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...